CCM Blood Biomarker Validation Study
Learn more about:
Related Clinical Trial
Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
CCM Blood Biomarker Validation Study
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Biomarkers of CASH
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study
Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina.
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Modifiers of Disease Severity in Cerebral Cavernous Malformations
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation